Combinations ; See Below
1. Mometasone Furoate
2. Mometasone furoate nasal spray
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Elocom | Schering-Plough (See also Essex Chemie) | Laborex Kenya Eurapharma Ltd | 0.10% | 15gm | Ointment | KES 586 | |
| Elocom | Schering-Plough (See also Essex Chemie) | Laborex Kenya Eurapharma Ltd | 0.10% | 30ml | lotion | KES 860 | |
| Momate | Glenmark | Harley's Limited | 0.10% | 15gm | Cream | KES 427.00 | |
| Momate | Glenmark | Harley's Limited | 0.10% | 15gm | Ointment | KES 365.00 | |
| Momtas | Cosme Pharma Ltd | Surgilinks Ltd. | 0.10% | 10gm | Ointment | KES 225 | |
| Topcort | Cipla Ltd. | Surgipharm Ltd | 0.1% | 15gm | Cream | KES 550.00 | |
| Topcort | Cipla Ltd. | Surgipharm Ltd | 0.1% | 15gm | Ointment | KES 550.00 |
| Mometasone Furoate More info | |
|---|---|
| Mode Of Action | It diffuses across cell membranes and forms a complex with specific cytoplasmic receptors. These complexes then enter the cell nucleus, binds to DNA, and stimulate transcription of messenger RNA (mRNA). Messenger RNA leads to protein synthesis of various enzymes that are responsible for the effects of systemic corticosteroids |
| Drug Indication | Relief of some inflammatory conditions when potentially less harmful measures are ineffective |
| Precautions | Limit use in children or on face to maximum of 5 days. It should be withdrawn gradually following prolonged therapy. Unless fully unavoidable, potent corticosteroids should not be used on the face as they may precipitate a rosacea-like disorder and aggravate any pre-existing rosacea, avoid use in an occluded area, near the eye, use in the presence of skin infections without concomitant use of anti-microbial, children under 1yr, on weeping foci. |
| Contra-Indications | Use on rosacea acne, peri-oral dermatitis, scabies, leg ulcers, tuberculous, untreated viral, bacterial or fungal infections, reaction to smallpox vaccination, first three months of pregnancy, continous prophylactic use. |
| Side Effects | Local irritation e.g burning sensation and itching, erythema rare, dryness of the skin, aggravation of concurrent untreated infections, thinning of the skin (this may be reversible), loss of skin elasticity, folliculitis, change in skin pigmentation, telangiectasia, purpura and steroid acne, increased growth of hair, severe pituitary-adrenal axis suppression and hypercotism, cushoid state, growth retardation, benign intra-cranial hypertension. |
| Dosage | Applied once daily |
| Drug Category | DERMATOLOGICAL PREPARATIONS |
| Drug Sub-Category | Topical Corticosteroids |
| 2. Mometasone furoate nasal spray | |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Indication | Prophylaxis and treatment of seasonal and perennial allergic rhinitis and hay fever | ||||||||||||||||||||||||||||||||||||||||
| Precautions | Treatment of the infections of the nose and pharynx before using this medicine; gradual withdrawal of exogenous steroids; transfer of patients from systemic steroid treatment; nasal trauma; recent nasal surgery. | ||||||||||||||||||||||||||||||||||||||||
| Contra-Indications | History of recurrent nasal bleeding; untreated bacterial/viral/fungal infections; children under 6yrs; unhealed nasal wound; pregnancy. | ||||||||||||||||||||||||||||||||||||||||
| Side Effects | Epistaxis; nasal septum perforation; unpleasant taste and smell; glaucoma; increase IOP; haemorrhagic nasal discharge; stuffy nose; local candidal infections | ||||||||||||||||||||||||||||||||||||||||
| Dosage | Dose: Children 6-11years: inhale 50mcg into each nostril once daily. Adults and children over 12years: inhale two sprays once daily (preferably in the morning) to a max. of 4 sprays daily then 50mcg into each nostril once daily after control has been achieved. | ||||||||||||||||||||||||||||||||||||||||
| Drug Category | DRUGS ACTING ON ENT | ||||||||||||||||||||||||||||||||||||||||
| Drug Sub-Category | Steroid hormones and related synthetic drugs
|
||||||||||||||||||||||||||||||||||||||||